Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-02
2006-05-02
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S266400, C514S269000, C514S235800, C544S320000, C544S319000, C544S270000, C544S122000, C544S123000, C544S114000, C544S115000
Reexamination Certificate
active
07037916
ABSTRACT:
Compounds containing the pyrimidine nucleus and their use to treat diseases and conditions related to inappropriate Interleukin-8 receptor activity are disclosed. The compounds are of the formula IIn these compounds, Q is preferably unsubstituted and substituted heterocyclyl; U is usually hydrogen or fluorine; and V is preferably hydrogen, halogen, alkyl, —O—alkyl or —S-alkyl. A representative example is:
REFERENCES:
patent: 5780483 (1998-07-01), Widdowson et al.
patent: 5972946 (1999-10-01), Murata et al.
patent: 6458798 (2002-10-01), Fujita et al.
patent: 2002/0065270 (2002-05-01), Moriarty et al.
patent: 2003/0097004 (2003-05-01), Taveras et al.
patent: 2003/0139435 (2003-07-01), Ahmed et al.
patent: 0257850 (1988-03-01), None
patent: 0 640 599 (1995-05-01), None
patent: 2139623 (1984-11-01), None
patent: 4-1192 (1992-01-01), None
patent: 10 130150 (1998-05-01), None
patent: WO 97/25324 (1997-07-01), None
patent: WO 97/37079 (1998-08-01), None
patent: WO 98/37079 (1998-08-01), None
patent: WO 99/59980 (1999-11-01), None
patent: WO 01/05783 (2001-01-01), None
patent: WO 03/077656 (2003-09-01), None
patent: WO 2004/018435 (2004-03-01), None
patent: WO 2004/063192 (2004-07-01), None
patent: WO 2004/069829 (2004-08-01), None
Corona et al. “Synthesis and in vitro study of platelet antiaggregant activity . . .”Eur.J. Med. Chem. 26, 729-733 (1991).
E. F. Elslager et al.: “Synthesis and Antimalarial Effects of 1-(3,4-Dichlorophenyl)-3-′4-′)1-ethyl-3-plperidyl)amlno!-6-methyl-2-pyrimidinyl!guan idine and Related Substances”, J. Med. Chem., vol. 17, No. 1, 1974, pp. 75-100, XP002297230, Table 1.
Baldwin John J.
Bohnstedt Adolph C
Conti Paolo Giovanni Martino
Dolle, III Roland Ellwood
Erickson Shawn David
Hansen Philip E.
Heslin Rothenberg Farley & & Mesiti P.C.
Krishnan Ganapathy
Pharmacopeia Drug Discovery Inc.
Wilson James O.
LandOfFree
Pyrimidine derivatives as IL-8 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives as IL-8 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives as IL-8 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3597492